NEW YORK (Reuters Health) – A meta-analysis of individual patient data found no differences in overall survival, progression-free survival, and objective response rate between cisplatin- and carboplatin-based chemotherapy…
NEW YORK (Reuters Health) – In looking back at more than 30,000 patients who had major open abdominal surgery over a five-year period, researchers found that those who…
NEW YORK (Reuters Health) – Therapeutic oral anticoagulation with warfarin, without extra heparins, provides sufficient anticoagulation for patients on long-term warfarin who need primary percutaneous coronary intervention (PCI),…
NEW YORK (Reuters Health) – It’s safe and beneficial to start small volumes of milk feeds early, between 24 and 48 hours after birth, in babies who are…
NEW YORK (Reuters Health) – Adjuvant tamoxifen after surgery and radiation reduces subsequent ipsilateral and contralateral breast cancers in women with estrogen-receptor (ER)-positive ductal carcinoma in situ (DCIS),…
NEW YORK (Reuters Health) – Bisphosphonate therapy doesn’t slow progression of aortic stenosis, according to the largest study to date to assess the effect of bisphosphonates on valvular…
NEW YORK (Reuters Health) – An episode of herpes zoster is associated with an increased risk of developing anterior uveitis in the following year, according to the results…
NEW YORK (Reuters Health) – A Japanese team has confirmed endoscopically that when a standard once-daily dose of rabeprazole fails to resolve reflux esophagitis, a twice-daily regimen may…
NEW YORK (Reuters Health) – A multicenter center study has shown that adding cetuximab to neoadjuvant chemotherapy and preoperative radiotherapy improves overall survival after excision of high-risk rectal…
NEW YORK (Reuters Health) – Contrary to previous reports, losartan is not associated with increased mortality risk in patients with heart failure, according the results of a Danish…